| O-(2-(18F) fluoroethyl)-L-tyrosine PET for the differentiation of tumour recurrence from late pseudoprogression in glioblastoma MI Mihovilovic, O Kertels, H Hänscheid, M Löhr, CM Monoranu, I Kleinlein, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (2), 238-239, 2019 | 34 | 2019 |
| Clinical utility of different approaches for detection of late pseudoprogression in glioblastoma with O-(2-[18F] fluoroethyl)-L-tyrosine PET O Kertels, MI Mihovilovic, T Linsenmann, AF Kessler, J Tran-Gia, ... Clinical Nuclear Medicine 44 (9), 695-701, 2019 | 18 | 2019 |
| Prognostic Value of O-(2-[18F]Fluoroethyl)-L-Tyrosine PET/CT in Newly Diagnosed WHO 2016 Grade II and III Glioma O Kertels, AF Kessler, MI Mihovilovic, A Stolzenburg, T Linsenmann, ... Molecular Imaging and Biology 21, 1174-1181, 2019 | 7 | 2019 |
| [18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making? O Kertels, J Krauß, CM Monoranu, S Samnick, A Dierks, M Kircher, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (6), 1699-1708, 2023 | 4 | 2023 |
| [18F] FET-PET/CT as a prognostic factor in newly-diagnosed gliomas II and III O Kertels, A Stolzenburg, M Mihovilovic, A Kessler, S Samnick, ... Journal of Nuclear Medicine 59 (supplement 1), 1690-1690, 2018 | 1 | 2018 |
